Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2016 · research · Research Grant
The Determinants and Functional Consequences of LRRK2 Dimer Formation
Hardy J. Rideout · Biomedical Research Foundation of the Academy of Athens
2016 · research · Target Advancement Program
Pharmacological Targeting of Proinflammatory Kinase Signaling in Parkinson's Disease
Richard Gordon · Queensland University of Technology
2016 · research · Target Advancement Program
Validation of the 18kDa Translocator Protein as a Novel Immunomodulator to Slow Progression in Parkinson's Disease
David Ryan Jacoby Owen · Imperial College London
2016 · research · Therapeutic Pipeline Program
Targeting Nicotinic Receptors to Increase Dopamine Function in Parkinson's Disease
Tino Dyhring · Saniona A/s
2016 · research · Research Grant
Investigation of LRRK2 as a Regulator of Dendritic Cell Function
David N. Irani · University of Michigan
2016 · research · Target Advancement Program
Role of Inflammation in Parkinson's Disease
Tomas Deierborg · Lund University
2016 · research · Target Advancement Program
Genetic Modulation of LAMP-2A in PD Models
David Sulzer · Research Foundation For Mental Hygiene/ New York State Psychiatric Institute/ Columbia University
2016 · research · Research Grant
LRRK2 Biomarker Initiative: Detection of LRRK2 in Cerebrospinal Fluid
Jean-Marc Taymans · Umr-s1172, Jean-pierre Aubert Research Center (inserm - Lille University - Lille University Hospital
2016 · research · Research Grant
Production of Helper Dependent Adenovirus Type 5 LRRK2 Expression Vectors
Ronald J. Mandel · University of Florida
2016 · research · Target Advancement Program
Assessing the Role of Glucosylceramide in Alpha-synuclein-induced Toxicity
Joseph R. Mazzulli · Northwestern University
2016 · research · Target Advancement Program
LRRK2 Kinase Activity and Mitochondrial DNA Damage in Parkinson's Disease
J. Timothy Greenamyre · University of Pittsburgh
2016 · research · Research Grant
Novel Quantification in Parkinson’s Disease Neurochemical Imaging
Arman Rahmim · Johns Hopkins University
2016 · research · Research Grant
Registry for the Advancement of Deep Brain Stimulation Therapy in Parkinson's Disease (RAD-PD)
Joohi Jimenez-Shahed · Icahn School of Medicine at Mount Sinai
2016 · research · Therapeutic Pipeline Program
Cognitive Behavioral Therapy for Anxiety Disorders in Parkinson's Disease
Albert F. G. Leentjens · Maastricht University Medical Centre
2016 · research · Research Grant
Parkinson's Disease Research Database
Kelly Dakin · Harvard University
2016 · research · Target Advancement Program
Role of LRRK2 in GCase-mediated Alterations in Lysosome Function and Alpha-synuclein Metabolism
Jason Schapansky · Brigham and Women's Hospital
2016 · research · Target Advancement Program
Alpha-synuclein-induced Astroglial Inflammation as a Trigger of Parkinson's Disease
Laurent Roybon · Van Andel Institute
2016 · research · Research Grant
Patient-Carer-Provider Communication about the Impact of Motor and Non-motor Fluctuations
Anna R. Gagliardi · Toronto General Hospital Research Institute
2016 · research · Research Grant
Inhibition of Striatal-enriched Phosphate (STEP) to Improve Parkinson-related Cognitive Dysfunction
Jay S. Schneider · Thomas Jefferson University
2016 · research · Improved Biomarkers and Clinical Outcome Measures
Study of Drug Binding Sites in Alpha-synuclein Fibrils
Rasmus Jan Linser · The Department For Nmr-based Structural Biology At Max Planck Institute For Biophysical Chemistry
2016 · research · Target Advancement Program
Investigation of Lipid Metabolism in GBA-associated Parkinsonism
Marzena Kurzawa-Akanbi · Newcastle University
2016 · research · Target Advancement Program
Identifying Enzymes to Stimulate Alpha-synuclein Degradation
Clarissa Waites · Columbia University
2016 · research · Biomarkers Across Neurodegenerative Diseases
Seeds of Dementia: Misfolded Proteins in Neurodegenerative Disorders
Fabio Moda · Fondazione IRCCS Istituto Neurologico Carlo Besta
2016 · research · Target Advancement Program
Role of GTPase Activity in Neurodegenerative Phenotypes Induced by G2019S LRRK2 in a Pre-clinical Model of Parkinson’s Disease
Darren J. Moore · Van Andel Institute
2016 · research · Target Advancement Program
Evaluation of PARIS (ZNF746) as a Target of Alpha-synuclein Toxicity in Parkinson's Disease and Alpha-synucleinopathies
Ted M. Dawson · Johns Hopkins University
2016 · research · Research Grant
Modelling LRRK2 Structure and Characterizing the LRRK2 Activation Cycle in LRRK2-mediated Parkinson's disease
Arjan Kortholt · University of Groningen
2016 · research · Research Grant
Investigation of the Role of PINK1-dependent Phosphorylation of Rab GTPases in Parkinson’s Disease
Miratul Muqit · University of Dundee
2016 · research · Improved Biomarkers and Clinical Outcome Measures
Developing New Method for GBA sequencing and Detection of Germ-line or Somatic Point Mutations, Deletion/Insertions and Recombinations with the GBA Pseudo Gene
Max Jan Van Min · Cergentis (Netherlands)
2016 · research · Target Advancement Program
Targeting the Mitochondrial Unfolded Protein Response in Alpha-synuclein-induced Parkinson's Disease
Xin Qi · Case Western Reserve University
2016 · research · Therapeutic Pipeline Program
Highly Selective M1 Muscarinic Receptor Positive Allosteric Modulators for the Treatment of Parkinson's Dementia
Christoph Wiessner · Asceneuron S.a.
2016 · research · Research Grant
Mechanisms of LRRK2 Membrane Association
Matthew S. Goldberg · University of Alabama at Birmingham
2016 · research · Improved Biomarkers and Clinical Outcome Measures
Supramolecular Hosts as Combined Protein Aggregation Inhibitors and Hyperpolarized MRI Reporters
Leif Schröder · Leibniz-institut F
2016 · research · Research Grant
Role of the JAK/STAT Pathway in Parkinson's Disease
Etty (Tika) N. Benveniste · University of Alabama at Birmingham
2016 · research · Improved Biomarkers and Clinical Outcome Measures
Brainstem and Olfactory System Biomarkers of Early Parkinson's Disease
Richard Doty · University of Pennsylvania
2016 · research · Research Grant
Planning Phase for a Phase IIa Study of Nilotinib in People with Parkinson's Disease
Tanya Simuni · Northwestern University
2016 · research · Target Advancement Program
Upregulation of Autophagy by Tet3-mediated 5-methylcytosine oxidation – Relevance to Parkinson's Disease
Gerd Pfeifer · Center For Epigenetics
2016 · research · Research Grant
Identification of Genetic Signatures in the Blood as Biomarkers for Parkinson's Disease
Paula A. Desplats · University of California San Diego
2016 · research · Target Advancement Program
Assessing the PINK1 Pathway in Parkinson
Garrett Geoffrey Gross · University of Southern California
2016 · research · Target Advancement Program
Protecting Dopamine Neurons in Parkinson's Disease
Rory A. Fisher · University of Iowa
2016 · research · Research Grant
Design and Identification of a LRRK2 Kinase Structural Surrogate
Arjan Kortholt · University of Groningen